neurodegenerative disorders

CuraSen Therapeutics Announces $54.5 Million Series A Financing to Develop Drugs Targeting Novel Mechanism for the Treatment of Neurodegenerative Diseases

Cision – CuraSen is developing small molecule drugs targeting a novel mechanism in the brain to alleviate disabling symptoms and modify disease pathology in patients who suffer from less common (orphan) neurodegenerative disorders as well as Parkinson's Disease and Alzheimer's Disease.